1. Home
  2. IKNA vs CEV Comparison

IKNA vs CEV Comparison

Compare IKNA & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • CEV
  • Stock Information
  • Founded
  • IKNA 2016
  • CEV 1999
  • Country
  • IKNA United States
  • CEV United States
  • Employees
  • IKNA N/A
  • CEV N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • CEV Finance/Investors Services
  • Sector
  • IKNA Health Care
  • CEV Finance
  • Exchange
  • IKNA Nasdaq
  • CEV Nasdaq
  • Market Cap
  • IKNA 74.8M
  • CEV 75.9M
  • IPO Year
  • IKNA 2021
  • CEV N/A
  • Fundamental
  • Price
  • IKNA $1.57
  • CEV $10.13
  • Analyst Decision
  • IKNA Buy
  • CEV
  • Analyst Count
  • IKNA 2
  • CEV 0
  • Target Price
  • IKNA $3.00
  • CEV N/A
  • AVG Volume (30 Days)
  • IKNA 399.7K
  • CEV 19.6K
  • Earning Date
  • IKNA 11-07-2024
  • CEV 01-01-0001
  • Dividend Yield
  • IKNA N/A
  • CEV 4.23%
  • EPS Growth
  • IKNA N/A
  • CEV N/A
  • EPS
  • IKNA N/A
  • CEV 0.36
  • Revenue
  • IKNA $659,000.00
  • CEV N/A
  • Revenue This Year
  • IKNA N/A
  • CEV N/A
  • Revenue Next Year
  • IKNA N/A
  • CEV N/A
  • P/E Ratio
  • IKNA N/A
  • CEV $29.36
  • Revenue Growth
  • IKNA N/A
  • CEV N/A
  • 52 Week Low
  • IKNA $1.22
  • CEV $8.83
  • 52 Week High
  • IKNA $2.17
  • CEV $10.91
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 42.72
  • CEV 31.55
  • Support Level
  • IKNA $1.62
  • CEV $10.01
  • Resistance Level
  • IKNA $1.94
  • CEV $10.75
  • Average True Range (ATR)
  • IKNA 0.10
  • CEV 0.09
  • MACD
  • IKNA -0.01
  • CEV -0.05
  • Stochastic Oscillator
  • IKNA 16.85
  • CEV 16.22

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

Share on Social Networks: